Skip to main content
Premium Trial:

Request an Annual Quote

BD Biosciences Gets Access to Canadian Gene and Protein Database

NEW YORK, Sept. 10 - BD Biosciences and the Canadian Network for Vaccines and Immunotherapeutics today said they have teamed up to develop antibodies and immune function assays.


CANVAC, a network of 72 Canadian scientists and their affiliated institutions, will give BD Biosciences exclusive access to its collection of full-length gene clones and proteins. BD Biosciences will use the clones for antibody development, according to the company.


Access to CANVAC's database will be handled by two of its member institutions: the University Health Network based in Toronto and Université de Montréal.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.